Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Lung, Non Small Cell
Phase III
Adults
Chemotherapy - cytotoxic, Mol. targeted/Immunotherapy/Biologics
Carboplatin, MK-3475, Pembrolizumab (MK-3475), Pemetrexed
York, Sally
National
Vanderbilt University
08-23-2019
Treatment
ECOGTHOEA5163
NCT03793179

Eligibility

Not Available
Not Available
Not Available

To learn more about any of our clinical
trials, call 615-936-8422.